Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Oncology Generic Injectable Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Generic Injectable Drugsmarket, defines the market attractiveness level of Oncology Generic Injectable Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oncology Generic Injectable Drugs industry, describes the types of Oncology Generic Injectable Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Generic Injectable Drugs market and the development prospects and opportunities of Oncology Generic Injectable Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Generic Injectable Drugs market in Chapter 13.
By Player:
AstraZeneca
Novartis
Pfizer
GlaxoSmithKline
Roche
Teva Pharmaceutical
Mylan
Eli Lilly
Natco Pharma
By Type:
Large Molecule Drugs
Small Molecule Drugs
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oncology Generic Injectable Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oncology Generic Injectable Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oncology Generic Injectable Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oncology Generic Injectable Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oncology Generic Injectable Drugs Market Analysis and Outlook to 2022
-
7.1 Global Oncology Generic Injectable Drugs Consumption (2017-2022)
-
7.2 United States Oncology Generic Injectable Drugs Consumption (2017-2022)
-
7.3 Europe Oncology Generic Injectable Drugs Consumption (2017-2022)
-
7.4 China Oncology Generic Injectable Drugs Consumption (2017-2022)
-
7.5 Japan Oncology Generic Injectable Drugs Consumption (2017-2022)
-
7.6 India Oncology Generic Injectable Drugs Consumption (2017-2022)
-
7.7 South Korea Oncology Generic Injectable Drugs Consumption (2017-2022)
8 Region and Country-wise Oncology Generic Injectable Drugs Market Analysis and Outlook to 2028
-
8.1 Global Oncology Generic Injectable Drugs Consumption Forecast (2022-2028)
-
8.2 United States Oncology Generic Injectable Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Oncology Generic Injectable Drugs Consumption Forecast (2022-2028)
-
8.4 China Oncology Generic Injectable Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Oncology Generic Injectable Drugs Consumption Forecast (2022-2028)
-
8.6 India Oncology Generic Injectable Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Oncology Generic Injectable Drugs Consumption Forecast (2022-2028)
9 Global Oncology Generic Injectable Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Oncology Generic Injectable Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Large Molecule Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Small Molecule Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Oncology Generic Injectable Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Oncology Generic Injectable Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Oncology Generic Injectable Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Large Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oncology Generic Injectable Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Oncology Generic Injectable Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oncology Generic Injectable Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oncology Generic Injectable Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oncology Generic Injectable Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oncology Generic Injectable Drugs Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Oncology Generic Injectable Drugs Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Oncology Generic Injectable Drugs Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Oncology Generic Injectable Drugs Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Oncology Generic Injectable Drugs Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Oncology Generic Injectable Drugs Product and Service
-
14.6 Teva Pharmaceutical
-
14.6.1 Teva Pharmaceutical Company Details
-
14.6.2 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Product and Service
-
14.7 Mylan
-
14.7.1 Mylan Company Details
-
14.7.2 Mylan Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Mylan Oncology Generic Injectable Drugs Product and Service
-
14.8 Eli Lilly
-
14.8.1 Eli Lilly Company Details
-
14.8.2 Eli Lilly Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Eli Lilly Oncology Generic Injectable Drugs Product and Service
-
14.9 Natco Pharma
-
14.9.1 Natco Pharma Company Details
-
14.9.2 Natco Pharma Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Natco Pharma Oncology Generic Injectable Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oncology Generic Injectable Drugs
-
Figure Oncology Generic Injectable Drugs Picture
-
Table Global Oncology Generic Injectable Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Generic Injectable Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oncology Generic Injectable Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oncology Generic Injectable Drugs Consumption by Country (2017-2022)
-
Figure United States Oncology Generic Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Oncology Generic Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Oncology Generic Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Oncology Generic Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Oncology Generic Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oncology Generic Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Generic Injectable Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Oncology Generic Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oncology Generic Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oncology Generic Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oncology Generic Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oncology Generic Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oncology Generic Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Large Molecule Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Small Molecule Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Large Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small Molecule Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oncology Generic Injectable Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oncology Generic Injectable Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Oncology Generic Injectable Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Oncology Generic Injectable Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Oncology Generic Injectable Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Oncology Generic Injectable Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Oncology Generic Injectable Drugs Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Oncology Generic Injectable Drugs Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Oncology Generic Injectable Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Oncology Generic Injectable Drugs Product and Service
-
Table Natco Pharma (Foundation Year, Company Profile and etc.)
-
Table Natco Pharma Oncology Generic Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natco Pharma Oncology Generic Injectable Drugs Product and Service
-
